Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Responses”

3,742 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,742 results

Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)WithdrawnNCT03872505
What this trial is testing

Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Cedars-Sinai Medical Center
Not applicableNot Yet RecruitingNCT06193122
What this trial is testing

Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 200
Testing effectiveness (Phase 2)UnknownNCT03242551
What this trial is testing

Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
Breast Neoplasms
Shenzhen People's Hospital 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06552572
What this trial is testing

Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Samsung Medical Center 30
Not applicableStudy completedNCT05462795
What this trial is testing

Liquid Biopsy for Early Non-small Lung Cancer Detection

Who this might be right for
Non Small-cell Lung Cancer
University of Arizona 171
Not applicableUnknownNCT05217212
What this trial is testing

Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Luzerner Kantonsspital 100
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Large-scale testing (Phase 3)Study completedNCT00960440
What this trial is testing

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
Pfizer 399
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Testing effectiveness (Phase 2)Study completedNCT03199274
What this trial is testing

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Thomas Jefferson University 104
Early research (Phase 1)Study completedNCT00095160
What this trial is testing

Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors

Who this might be right for
Neoplasms
Masonic Cancer Center, University of Minnesota 42
Testing effectiveness (Phase 2)Looking for participantsNCT06001658
What this trial is testing

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Who this might be right for
Billiary Track Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Testing effectiveness (Phase 2)WithdrawnNCT02115035
What this trial is testing

A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib

Who this might be right for
Multiple Myeloma
University of Arkansas
Not applicableStudy completedNCT05062525
What this trial is testing

Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients

Who this might be right for
COVID-19Cancer
University Health Network, Toronto 53
Not applicableLooking for participantsNCT06804135
What this trial is testing

Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer

Who this might be right for
Cervical Carcinoma
Tata Memorial Hospital 110
Large-scale testing (Phase 3)Looking for participantsNCT04749108
What this trial is testing

Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

Who this might be right for
Locally Advanced Malignant NeoplasmRectal Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 1,075
Not applicableLooking for participantsNCT07370597
What this trial is testing

LUtetium-177 DOsimetry as a Predictive Biomarker of Response in Metastatic Prostate Cancer Patients Treated With PSMA Radioligand THerapy.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Jules Bordet Institute 110
Very early researchTemporarily pausedNCT04494113
What this trial is testing

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Who this might be right for
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI) 12
Not applicableUnknownNCT02765620
What this trial is testing

PERCIST Criteria for Response Evaluation With Solid Tumors

Who this might be right for
Lung NeoplasmsBreast NeoplasmsColonic Neoplasms+1 more
Tianjin Medical University Cancer Institute and Hospital 150
Load More Results